Loading...
Market
Primary Outcome of Malaysian Chemsex App Project by End of 2025?
2
Resolution / Starting Odds
Project completed successfully • 25%
Project halted or canceled • 25%
Project receives additional criticism • 25%
Project receives additional funding • 25%
Project reports, NIH official statements, or academic publications
Story
Biden-Harris Administration Allocates $3.4 Million for Malaysian Chemsex App
Nov 22, 2024, 04:57 PM
The Biden-Harris administration is facing scrutiny for allocating millions of dollars to fund a project aimed at developing an app to advise gay men on how to safely engage in drug-fueled intercourse, commonly referred to as 'chemsex.' The project, which has received a $3.4 million grant from the National Institutes of Health (NIH), is being led by a professor from the University of Connecticut (UConn) and is specifically targeted at Malaysian gay men. This initiative has sparked controversy and criticism from various quarters, with some questioning the use of taxpayer money for such purposes.
View original story
Similar markets
Reduction in incidents • 25%
Increased awareness • 25%
Improved safety perception • 25%
No significant change • 25%
PrEP Usage • 25%
Testing and Diagnosis • 25%
Public Awareness Campaigns • 25%
Treatment Programs • 25%
Increase by more than 20% • 33%
Increase by less than 20% • 33%
No significant change • 33%
Increased arrests • 25%
New legislation • 25%
Improved public perception • 25%
No significant change • 25%
0-2 • 25%
3-5 • 25%
6-8 • 25%
9 or more • 25%
Adopted by major conservative organizations • 25%
Endorsed by Trump • 25%
Modified and rebranded • 25%
Remains largely ignored • 25%
HIV/AIDS • 25%
Genital Herpes • 25%
HPV • 25%
Other • 25%
Significant decrease in syphilis cases • 25%
Moderate decrease in syphilis cases • 25%
No significant change in syphilis cases • 25%
Increase in syphilis cases • 25%
Vaccine testing reform • 25%
Chronic disease initiative • 25%
FDA/CDC restructuring • 25%
Other initiative • 25%
Significant reduction in crisis • 25%
Moderate reduction in crisis • 25%
No significant change • 25%
Worsening of crisis • 25%
Cost • 25%
Distribution • 25%
Adherence • 25%
Regulatory Approval • 25%